Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 45 Breast Neoplasms 39 Triple Negative Breast Neoplasms 19 Prostatic Neoplasms 17 Neoplasms 13 Fallopian Tube Neoplasms 13 Endometrial Neoplasms 12 Recurrence 8 Pancreatic Neoplasms 8 Neoplasm Metastasis 8 Squamous Cell Carcinoma of Head and Neck 7 Small Cell Lung Carcinoma 7 Lung Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Glioma 5 Glioblastoma 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Sarcoma 4 Carcinoma, Squamous Cell 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Breast Cancer 4 Stomach Neoplasms 3 Solid Tumor 3 Melanoma 3 Head and Neck Neoplasms 3 Fanconi Anemia, Complementation Group D1 3 Uveal Melanoma 2 Uterine Neoplasms 2 Urinary Bladder Neoplasms 2

Interventions

Radiotherapy 24 Radiotherapy, Intensity-Modulated 8 Radiosurgery 6 Amifostine 5 Low-Level Light Therapy 4 Donepezil 4 Cisplatin 4 Carboplatin 4 Surveys and Questionnaires 3 Radiation 3 Proton Therapy 3 Paclitaxel 3 Neuropsychological Tests 3 Heavy Ion Radiotherapy 3 Etoposide 3 Chemotherapy, Adjuvant 3 Chemoradiotherapy 3 Brachytherapy 3 Bevacizumab 3 Surgical Procedures, Operative 2 Radiation Dose Hypofractionation 2 Patient Reported Outcome Measures 2 Mental Status and Dementia Tests 2 Esophagectomy 2 Androgen Antagonists 2 Adrenal Cortex Hormones 2 sodium propionate 1 sargramostim 1 olaparib 1 endostar protein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Radiation Injuries × olaparib × Clear all

NCT03109080 2025-11-24

RadioPARP

Institut Curie

Phase 1 Completed

Radiation Injuries, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡